Baloh Robert H, Salavaggione Ezequiel, Milbrandt Jeffrey, Pestronk Alan
Department of Neurology, Washington University School of Medicine, PO Box 8111, 660 S Euclid Ave, St Louis, MO 63110, USA.
Arch Neurol. 2007 Jul;64(7):998-1000. doi: 10.1001/archneur.64.7.998.
To describe the clinical phenotype and genetic basis of a family with autosomal dominant progressive external ophthalmoplegia and parkinsonism from a Twinkle mutation.
All coding exons of POLG1, Twinkle (aka C10ORF2, PEO1), and ANT1 (SLC25A4) were sequenced in the proband with targeted sequencing of the Twinkle gene in all additional subjects.
Members of a 3-generation family followed up in a neuromuscular disease center for dominantly inherited progressive external ophthalmoplegia.
We identified a heterozygous G1121A mutation (R374Q) in exon 1 of Twinkle that segregated with the disease phenotype in all affected family members. No pathogenic mutations were present in POLG1 or ANT1.
This finding broadens the clinical spectrum of Twinkle gene mutations and further implicates loss of mitochondrial DNA integrity in the pathogenesis of Parkinson disease.
描述一个因Twinkle基因突变导致常染色体显性遗传性进行性眼外肌麻痹和帕金森症的家系的临床表型及遗传基础。
对先证者的POLG1、Twinkle(又名C10ORF2、PEO1)和ANT1(SLC25A4)的所有编码外显子进行测序,并对所有其他受试者的Twinkle基因进行靶向测序。
一个三代家系的成员,在神经肌肉疾病中心接受显性遗传性进行性眼外肌麻痹的随访。
我们在Twinkle基因的第1外显子中鉴定出一个杂合的G1121A突变(R374Q),该突变在所有受影响的家庭成员中与疾病表型共分离。POLG1或ANT1中未发现致病突变。
这一发现拓宽了Twinkle基因突变的临床谱,并进一步提示线粒体DNA完整性的丧失在帕金森病发病机制中的作用。